Human CD40L ELISA Kit | RayBiotech
CD40L and its receptors: the binding of CD40L to CD40, αIIbβ3, α5β1, or... | Download Scientific Diagram
-Western-Blot-NBP2-66756-img0007.jpg "CD40 Ligand/TNFSF5 Antibody (JM11-34) (NBP2-66756): Novus Biologicals")
CD40 Ligand/TNFSF5 Antibody (JM11-34) (NBP2-66756): Novus Biologicals
Recombinant Rat CD40 Ligand/TNFSF5 (HA-tag) Protein (8414-CL): Novus Biologicals
Mouse CD40 Ligand/TNFSF5 Antibody MAB1163: R&D Systems
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint - ScienceDirect
Will Frexalimab replace the anti-CD20s?
Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling | ACS Applied Bio Materials
BLYS, CD40, CD86, and CD40L genotypes in relation to antibody titers... | Download Scientific Diagram
Human CD40 Ligand/TNFSF5/CD40LG ELISA Kit PicoKine® EK0573 | Boster Bio
Mouse CD40 Ligand/TNFSF5 Antibody AF1163: R&D Systems
CD40-CD40L interactions at DC-T cell and T cell-T cell interface.... | Download Scientific Diagram
Mouse CD40 Ligand/TNFSF5 Fluorescein-conjugated Antibody FAB1163F: R&D Systems
-Flow-Cytometry-NBP2-66756-img0001.jpg "CD40 Ligand/TNFSF5 Antibody (JM11-34) (NBP2-66756): Novus Biologicals")
CD40 Ligand/TNFSF5 Antibody (JM11-34) (NBP2-66756): Novus Biologicals
Will Frexalimab replace the anti-CD20s?
Frontiers | CD40L and Its Receptors in Atherothrombosis—An Update
CD40L (human) (multimeric) (recombinant protein) - AdipoGen Life Sciences - B cell Activation and Expansion - T cell activation - Anti-tumor immunity
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment | Gene Therapy
IJMS | Free Full-Text | CD40–CD40L in Neurological Disease
Recombinant Mouse CD40 Ligand/TNFSF5 (HA-tag) Protein 8230-CL-050: R&D Systems
Mouse CD40 Ligand/TNFSF5 Antibody MAB1163: R&D Systems
CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines - Cytotherapy
Recombinant Human CD40 Ligand/TNFSF5 (aa 108-261) Protein 6245-CL-050: R&D Systems
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling | ACS Applied Bio Materials
CD40L upregulation assay
CD154 - Wikipedia
